Brief: Asit Biotech says active ingredients used in ASIT+ granted European patent

European Medical Solutions SA

17/10/2017 17:31

Oct 17 (Reuters) - ASIT BIOTECH SA  ASIT.BR : 
    * ASIT BIOTECH ANNOUNCES THE GRANT OF A EUROPEAN PATENT ON 
THE ACTIVE INGREDIENTS USED IN THE ASIT+ ALLERGY IMMUNOTHERAPY 
PRODUCT CANDIDATES 
    * GRANT WILL BE EFFECTIVE FROM NOVEMBER 1, 2017 UNTIL JUNE 
28, 2027 WITH A POSSIBLE EXTENSION OF 5 YEARS 
 
Source text for Eikon:  ID:nBw4CCHFba  
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))